Baptist Medical Center - Yazoo, INC
Baptist Medical Center - Yazoo, INC was paid $1.80M by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 71% of everything it billed.
33Billing provider infoBAPTIST MEDICAL CENTER - YAZOO, INC
YAZOO CITY, MS 39194
YAZOO CITY, MS 39194
33aNPI1699066746assigned 04/25/2011
33bProvider typeSpecialist
28Total paid$1.80M
24GClaims74,910
24DCodes billed40
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Mississippi
Rank by total paid#5 of 103
Median peer was paid$86K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DUCKETT, GREGORY controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,608 | $245K | |
| 2019 | 9,824 | $438K | |
| 2020 | 8,198 | $269K | |
| 2021 | 8,317 | $248K | |
| 2022 | 10,107 | $157K | |
| 2023 | 27,281 | $313K | |
| 2024incomplete | 6,575 | $125K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 71% | 15,283 | 12,394 | $1.28M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 6,094 | 4,932 | $369K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.1% | 558 | 464 | $56K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.8% | 254 | 230 | $32K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.7% | 311 | 267 | $31K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,561 | 3,804 | $7K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 3,092 | 2,436 | $6K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 144 | 129 | $6K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 435 | 389 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 2,901 | 2,286 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 117 | 107 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,169 | 1,146 | $1K |
28 more codes
| 0012A | <1% | 68 | $704.35 | |
| 0011A | <1% | 89 | $628.73 | |
| 3078F | <1% | 5,760 | $384.48 | |
| 3079F | <1% | 2,287 | $382.80 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 96 | $355.38 |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 27 | $255.62 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 55 | $194.25 |
| 3077F | <1% | 3,433 | $193.16 | |
| 3008F | <1% | 8,547 | $170.64 | |
| 3080F | <1% | 1,100 | $169.72 | |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 110 | $165.49 |
| 3074F | <1% | 4,410 | $143.95 | |
| 90686 | <1% | 126 | $130.16 | |
| 0013A | <1% | 16 | $107.61 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 616 | $22.75 |
| 3075F | <1% | 1,515 | $20.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 338 | $6.72 |
| 1159F | 0% | 5,202 | $0.00 | |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 231 | $0.00 |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 0% | 24 | $0.00 |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 83 | $0.00 |
| 1160F | 0% | 2,920 | $0.00 | |
| 81025 | 0% | 114 | $0.00 | |
| 1125F | 0% | 819 | $0.00 | |
| 91301 | 0% | 78 | $0.00 | |
| 1126F | 0% | 879 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 29 | $0.00 |
| 90656 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDUCKETT, GREGORY (SR VP/CLO)
Parent organizationBAPTIST MEMORIAL HEALTH CARE CORP.
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.